NAGLAZYME (GALSULFASE) — FDA Approval BLA125117 (BIOMARIN)
NAGLAZYME (GALSULFASE) — FDA Approval BLA125117 (BIOMARIN) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: NAGLAZYME; Active ingredients: GALSULFASE; Application number: BLA125117.
| Brand name | NAGLAZYME |
|---|---|
| Active ingredients | GALSULFASE |
| Application number | BLA125117 |
| Sponsor | BIOMARIN |
| Dosage form | INJECTABLE |
| Route | INJECTION |
| Marketing status | Prescription |
| Products in application | 1 |
| First approval date | 20050531 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →